Glenmark Pharma surges after its arm gets USFDA’s tentative nod for Dapagliflozin, Saxagliptin Tablets

29 Apr 2020 Evaluate
Glenmark Pharmaceuticals is currently trading at Rs. 331.70, up by 3.90 points or 1.19% from its previous closing of Rs. 327.80 on the BSE.

The scrip opened at Rs. 330.00 and has touched a high and low of Rs. 335.20 and Rs. 325.90 respectively. So far 58683 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 653.60 on 30-Apr-2019 and a 52 week low of Rs. 168.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 361.00 and Rs. 321.30 respectively. The current market cap of the company is Rs. 9338.36 crore.

The promoters holding in the company stood at 46.59%, while Institutions and Non-Institutions held 37.20% and 16.21% respectively.

Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg, the generic version of Qtern 1 Tablets, 10 mg/5 mg, of AstraZeneca AB. According to IQVIA sales data for the 12 month period ending February 2020, the Qtern Tablets, 10 mg/5 mg market achieved annual sales of approximately $10.4 million.

Glenmark’s current portfolio consists of 162 products authorized for distribution in the U.S. marketplace and 44 ANDA’s pending approval with the USFDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1984.05 29.25 (1.50%)
19-Dec-2025 14:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.05
Dr. Reddys Lab 1276.30
Cipla 1511.20
Zydus Lifesciences 917.90
Lupin 2125.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×